Introduction: Development of specific biomarkers aiding early diagnosis of heart failure is an
ongoing challenge. Biomarkers commonly used in clinical routine usually act as readouts of …

Mass spectrometry-based proteomics is a sophisticated identification tool specializing in
portraying protein dynamics at a molecular level. Proteomics provides biologists with a …

Heart failure (HF) is a clinical syndrome caused by structural and/or functional cardiac
abnormalities and resulting from impaired cardiac output or an increase of intracardiac …

Artificial intelligence applications with clinically relevant models in transplant medicine have
the potential to optimize organ utilization, prediction of complications, and potential …

Proteomic analysis is having a rapid development as a method for the detection of
biomarkers of diseases in dogs. Dogs in addition to their importance as companion animals …

The primary purpose of 'omics' technologies is to understand the intricacy of genomics,
proteomics, metabolomics and other molecular mechanisms to reveal the complex traits of …

Cardiorenal syndromes (CRS) include a scenario of clinical interactions characterized by
the heart and kidney dysfunction. The crosstalk between cardiac and renal systems is clearly …

Myocardial infarction is a major cause of cardiac dysfunction. All components of the cardiac
renin–angiotensin system (RAS) are upregulated in myocardial infarction. Angiotensin …

Mitoxantrone (MTX) is used to treat several types of cancers and to improve neurological
disability in multiple sclerosis. Unfortunately, cardiotoxicity is a severe and common adverse …

Importance Heart failure (HF) and frailty frequently coexist and may share a common
pathobiology, although the underlying mechanisms remain unclear. Understanding these …